RTI Surgical Completes Acquisition of Collagen Solutions

RTI Surgical Completes Acquisition of Collagen Solutions

ALACHUA, Fla., November 1, 2024 – RTI Surgical (“RTI” or “the Company”), a leading CDMO pushing the boundaries of innovation and tissue engineering to meet patient needs in regenerative medicine, announced today it has successfully completed the acquisition of Collagen Solutions, a premier global supplier of engineered medical-grade collagen and xenograft tissue, as announced on October 7, 2024.

The acquisition further expands RTI’s uniquely comprehensive portfolio of allograft and xenograft biomaterials at scale, building on the Company’s acquisition of Cook Biotech earlier in the year. The combination brings specialized capabilities in bovine and porcine collagen materials and provides increased access to high-growth therapeutic areas such as cardiac, sports medicine and orthopedics, and plastic and reconstructive surgery. Together, the companies bring a combined 50 years of experience in developing products to help millions of patients in regenerative medicine.

Collagen Solutions is headquartered in Eden Prairie, Minnesota, with additional strategically located sites in the U.K. and New Zealand.

About RTI Surgical

RTI Surgical (RTI) is a leading CDMO (Contract Development and Manufacturing Organization) pushing the boundaries of innovation and tissue engineering to meet patient needs in regenerative medicine. We are expert partners to OEMs (Original Equipment Manufacturers), working with them to identify clinical problems and develop customized solutions that promote healing, accelerate recovery, and help prevent complications. Using our extensive portfolio of biological materials, we focus on specialized clinical segments, including plastic and reconstructive surgery, sports medicine and orthopedics, cardiac, and neuro and spine surgery. Headquartered in Alachua, Florida, RTI has manufacturing facilities in the United States and Europe. Montagu acquired RTI in a carve-out acquisition in July 2020. For more information, visit www.rtisurgical.com

Media Contact:
Amelia Bell
Tel: +1 386.418.5100
abell@rtix.com

ICR Healthcare
rtisurgical@icrhealthcare.com

Staff

Recent Posts

BioHarvest Sciences to Participate in Noble Capital Markets Emerging Growth Conference on December 3, 2024

Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 21, 2024) - BioHarvest Sciences Inc.…

45 minutes ago

Sound Physicians’ ACO Achieves $22.9M Total Savings in 2023 Medicare Shared Savings Program 

Ranks in Top 10 Percent of Total Shared SavingsTACOMA, WA / ACCESSWIRE / November 21,…

45 minutes ago

neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer

neurocare group AG, a best practice platform for mental health and performance, is pleased to…

45 minutes ago

Gaining Momentum, Biodexa is Advancing Two Recent Acquisitions Through the Clinic

CARDIFF, UK / ACCESSWIRE / November 21, 2024 / Biodexa Pharmaceuticals PLC (NASDAQ:BDRX), an acquisition-focused…

45 minutes ago

Solventless Cannabis Brand, Port North, Expands Operations to Lune Rise Farms Facilities

TORONTO, ON / ACCESSWIRE / November 21, 2024 / Justera Health Ltd. (CSE:VTAL)(OTC PINK:SCRSF) ("Justera"orthe"Company")…

45 minutes ago